Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 to 90

Investigating fluids for treating septic shock and intracranial hypertension

Official title: A Pilot, Randomized, Double-Blinded, Controlled Study of Hemodynamic and Acid Base Effects of 0.5M Sodium Lactate and 3% Saline Solutions in Septic Shock Patients

Run by University Hospital Pilsen · NCT06634069 · Data updated 2026-11-12

This study tests if two different fluids can help people with septic shock and high pressure in the brain feel better and improve their condition.

More Septic Shock trials

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years to 90 Years
SexAll
Enrollment40 (estimated)
SponsorUniversity Hospital Pilsen
Academic / other
Locations1 site (Pilsen, Czech Republic)
StatusRecruiting
StartedNovember 24, 2024
Main results expectedOctober 31, 2027
Study endsOctober 31, 2027
Registry record updatedApril 14, 2026
Trial IDNCT06634069 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 90 who meet the criteria for septic shock and require fluid resuscitation.

Probably not a fit

Patients who do not meet the septic shock criteria or are outside the age range of 18 to 90 may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study evaluates the effects of two resuscitation fluids, 0.5M Sodium Lactate and 3% Saline, on hemodynamic and acid-base balance in patients experiencing septic shock and intracranial hypertension. It employs a randomized, double-blinded, controlled design to ensure unbiased results. Participants will be closely monitored for changes in their condition following the administration of these fluids. The study aims to provide insights into the efficacy of these off-label treatments in critical care settings.

Why it matters

Potential benefit: If successful, this study could improve treatment outcomes for patients suffering from septic shock and intracranial hypertension.

How similar studies have gone: While the use of these fluids is off-label, similar studies have shown promise in treating septic shock, indicating potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subjects will be eligible for the trial if they meet all of the following criteria:

  1. Age criteria: 18 - 90 years
  2. Septic shock - Sepsis 3 criteria :

     1. acute change in total SOFA score ≥ 2 due to infection
     2. use of vasopressor drug to maintain target mean arterial pressure ≥ 65 mmHg
     3. blood lactate level ≥ 2 mmol/L within last 24 hours
  3. Likely need for fluid resuscitation

     1. poor peripheral perfusion as evidenced by 2 out of 4: i. peripheral cyanosis with delayed capillary refill ≥ 3 seconds ii. low urinary output (\< 0.5 ml/kg/hour for at least 6 hours) iii. central venous O2 saturation \< 70% iv. clouded sensorium/poor mentation
     2. dynamic assessment of preload responsiveness as evidenced by 1 out of 3: i. positive passive leg raising test ii. pulse pressure variation and / or stroke volume variation2, both \> 12% iii. distensibility index of inferior vena caval diameter \> 12%
  4. Signed the relevant informed consent form

Exclusion Criteria:

* Subjects will not be eligible for the trial if they meet any of the following criteria:

  1. Poor transthoracic echo windows
  2. Actual body weight \> 160 kg
  3. Hypernatremia: \[Na\] \> 150 mEq/L
  4. Cardiac tamponade
  5. Uncorrected severe valvular heart disease or life-threatening arrhythmia
  6. Moribund patients likely to die before the study protocol is completed
  7. Patients with absolute indication for immediate acute hemodialysis/hemofiltration (within 2 hrs) based on pH \< 7.0, K \> 7.0mmol/L
  8. Severe liver dysfunction defined by total serum bilirubin \> 120 umol/l
  9. Pregnancy and lactation

Where it's running

  • University Hospital Pilsen
    Pilsen, Czech Republic, Czechia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.